medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.medsovet-9964Research ArticleНОВОСТИ. ОТКРЫТИЯ И СОБЫТИЯNEWS, DISCOVERIES AND EVENTSПроблема назначения анксиолитиков при сердечно-сосудистых заболеваниях: взгляд невролога и кардиологаAddressing the issue of anxiolytics prescription in cardiovascular diseases: A perspective from the neurologist and cardiologistОстроумоваО. Д.OstroumovaO. D.

Остроумова Ольга Дмитриевна - доктор медицинских наук, профессор, заведующая кафедрой терапии и полиморбидной патологии имени академика М.С. Вовси ФГБОУ ДПО «РМАНПО» Минздрава РФ, председатель рабочей группы «Кардионеврология» Российского кардиологического общества (РКО), член президиума Московского общества кардиологов, председатель Московского регионального отделения Российского научного медицинского общества терапевтов (РНМОТ).

Olga D. Ostroumova - Dr. Sci. (Med.), Professor, Head of the Department of Therapy and Polymorbid Pathology named after Academician M.S. Vovsi, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Chair of the RSC Working Group on Cardioneurology, Member of the Presidium of the Moscow Society of Cardiology, Chairman of the Moscow Regional Branch of the Russian Scientific Medical Society of Internal Medicine (RNMOT).

ПарфеновВ. А.ParfenovV. A.

Парфенов Владимир Анатольевич - доктор медицинских наук, профессор, заведующий кафедрой нервных болезней Института клинической медицины ФГАОУ ВО «ПМГМУ им. И.М. Сеченова» Минздрава России (Сеченовский Университет).

Vladimir A. Parfenov - Dr. Sci. (Med.), Professor, Head of the Department of Nervous Diseases, Institute of Clinical Medicine, Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University).

ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РФРоссияRussian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian FederationRussian FederationФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)РоссияSechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)Russian Federation20261904202603816Copyright © Остроумова О.Д., Парфенов В.А., 20262026Остроумова О.Д., Парфенов В.А.Ostroumova O.D., Parfenov V.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/9964

Роль тревожных расстройств в развитии и прогрессировании сердечно-сосудистых заболеваний, их взаимосвязь и эффективные стратегии лечения коморбидных пациентов обсуждаем с нашими экспертами:

Ольга Дмитриевна Остроумова, доктор медицинских наук, профессор, заведующая кафедрой терапии и полиморбидной патологии имени академика М.С. Вовси ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РФ; председатель рабочей группы «Кардионеврология» Российского кардиологического общества (РКО), член президиума Московского общества кардиологов, председатель Московского регионального отделения Российского научного медицинского общества терапевтов (РНМОТ).

Владимир Анатольевич Парфенов, доктор медицинских наук, профессор, заведующий кафедрой нервных болезней Института клинической медицины ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет).

The role of anxiety disorders in the onset and progression of cardiovascular diseases, the relationship between them, and effective treatment strategies for comorbid patients have been discussed with our experts:

Olga D

Olga D. Ostroumova, Dr. Sci. (Med.), Professor, Head of the Department of Therapy and Polymorbid Pathology named after Academician M.S. Vovsi, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Chair of the RSC Working Group on Cardioneurology, Member of the Presidium of the Moscow Society of Cardiology, Chairman of the Moscow Regional Branch of the Russian Scientific Medical Society of Internal Medicine (RNMOT).

Vladimir A

Vladimir A. Parfenov, Dr. Sci. (Med.), Professor, Head of the Department of Nervous Diseases, Institute of Clinical Medicine, Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University).

ReferencesVaccarino V, Prescott E, Shah AJ, Bremner JD, Raggi P, Dobiliene O et al. Mental health disorders and their impact on cardiovascular health disparities. Lancet Reg Health Eur. 2025;56:101373. https://doi.org/10.1016/j.lanepe.2025.101373.Vaccarino V, Prescott E, Shah AJ, Bremner JD, Raggi P, Dobiliene O et al. Mental health disorders and their impact on cardiovascular health disparities. Lancet Reg Health Eur. 2025;56:101373. https://doi.org/10.1016/j.lanepe.2025.101373.Michal M, Beutel M. Mental disorders and cardiovascular disease: what should we be looking out for? Heart. 2021;107(21):1756–1761. https://doi.org/10.1136/heartjnl-2019-316379.Michal M, Beutel M. Mental disorders and cardiovascular disease: what should we be looking out for? Heart. 2021;107(21):1756–1761. https://doi.org/10.1136/heartjnl-2019-316379.Thurston RC, Rewak M, Kubzansky LD. An anxious heart: anxiety and the onset of cardiovascular diseases. Prog Cardiovasc Dis. 2013;55(6):524–537. https://doi.org/10.1016/j.pcad.2013.03.007.Thurston RC, Rewak M, Kubzansky LD. An anxious heart: anxiety and the onset of cardiovascular diseases. Prog Cardiovasc Dis. 2013;55(6):524–537. https://doi.org/10.1016/j.pcad.2013.03.007.Cohen BE, Edmondson D, Kronish IM. State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease. Am J Hypertens. 2015;28(11):1295–1302. https://doi.org/10.1093/ajh/hpv047.Cohen BE, Edmondson D, Kronish IM. State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease. Am J Hypertens. 2015;28(11):1295–1302. https://doi.org/10.1093/ajh/hpv047.Tully PJ, Harrison NJ, Cheung P, Cosh S. Anxiety and Cardiovascular Disease Risk: a Review. Curr Cardiol Rep. 2016;18(12):120. https://doi.org/10.1007/s11886-016-0800-3.Tully PJ, Harrison NJ, Cheung P, Cosh S. Anxiety and Cardiovascular Disease Risk: a Review. Curr Cardiol Rep. 2016;18(12):120. https://doi.org/10.1007/s11886-016-0800-3.Todaro JF, Shen BJ, Raffa SD, Tilkemeier PL, Niaura R. Prevalence of anxiety disorders in men and women with established coronary heart disease. J Cardiopulm Rehabil Prev. 2007;27(2):86–91. https://doi.org/10.1097/01.HCR.0000265036.24157.e7.Todaro JF, Shen BJ, Raffa SD, Tilkemeier PL, Niaura R. Prevalence of anxiety disorders in men and women with established coronary heart disease. J Cardiopulm Rehabil Prev. 2007;27(2):86–91. https://doi.org/10.1097/01.HCR.0000265036.24157.e7.Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol. 2010;56(1):38–46. https://doi.org/10.1016/j.jacc.2010.03.034.Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol. 2010;56(1):38–46. https://doi.org/10.1016/j.jacc.2010.03.034.Haftgoli N, Favrat B, Verdon F, Vaucher P, Bischoff T, Burnand B, Herzig L. Patients presenting with somatic complaints in general practice: depression, anxiety and somatoform disorders are frequent and associated with psychosocial stressors. BMC Fam Pract. 2010;11:67. https://doi.org/10.1186/1471-2296-11-67.Haftgoli N, Favrat B, Verdon F, Vaucher P, Bischoff T, Burnand B, Herzig L. Patients presenting with somatic complaints in general practice: depression, anxiety and somatoform disorders are frequent and associated with psychosocial stressors. BMC Fam Pract. 2010;11:67. https://doi.org/10.1186/1471-2296-11-67.Pogosova N, Boytsov S, De Bacquer D, Sokolova O, Ausheva A, Kursakov A, Saner H. Factors Associated with Anxiety and Depressive Symptoms in 2775 Patients with Arterial Hypertension and Coronary Heart Disease: Results from the COMETA Multicenter Study. Glob Heart. 2021;16(1):73. https://doi.org/10.5334/gh.1017.Pogosova N, Boytsov S, De Bacquer D, Sokolova O, Ausheva A, Kursakov A, Saner H. Factors Associated with Anxiety and Depressive Symptoms in 2775 Patients with Arterial Hypertension and Coronary Heart Disease: Results from the COMETA Multicenter Study. Glob Heart. 2021;16(1):73. https://doi.org/10.5334/gh.1017.Feigin VL, Krishnamurthi RV, Parmar P, Norrving B, Mensah GA, Bennett DA et al. Update on the global burden of ischemic and hemorrhagic stroke in 1990–2013: The GBD 2013 Study. Neuroepidemiology. 2015;45:161–176. https://doi.org/10.1159/000441085.Feigin VL, Krishnamurthi RV, Parmar P, Norrving B, Mensah GA, Bennett DA et al. Update on the global burden of ischemic and hemorrhagic stroke in 1990–2013: The GBD 2013 Study. Neuroepidemiology. 2015;45:161–176. https://doi.org/10.1159/000441085.Donnellan C, Hickey A, Hevey D, O’Neill D. Effect of mood symptoms on recovery one year after stroke. Int J Geriatr Psychiatry. 2010;25:1288–1295. https://doi.org/10.1002/gps.2482.Donnellan C, Hickey A, Hevey D, O’Neill D. Effect of mood symptoms on recovery one year after stroke. Int J Geriatr Psychiatry. 2010;25:1288–1295. https://doi.org/10.1002/gps.2482.Rafsten L, Danielsson A, Sunnerhagen KS. Anxiety after stroke: A systematic review and meta-analysis. J Rehabil Med. 2018;50(9):769–778. https://doi.org/10.2340/16501977-2384.Rafsten L, Danielsson A, Sunnerhagen KS. Anxiety after stroke: A systematic review and meta-analysis. J Rehabil Med. 2018;50(9):769–778. https://doi.org/10.2340/16501977-2384.Васильева АВ, Зинченко ЮП, Исаева ЕР, Караваева ТА, Мизинова ЕБ, Мосолов СН и др. Генерализованное тревожное расстройство: клинические рекомендации. 2024. Режим доступа: https://cr.minzdrav.gov.ru/preview-cr/457_3.Васильева АВ, Зинченко ЮП, Исаева ЕР, Караваева ТА, Мизинова ЕБ, Мосолов СН и др. Генерализованное тревожное расстройство: клинические рекомендации. 2024. Режим доступа: https://cr.minzdrav.gov.ru/preview-cr/457_3.Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation. 1994;90(5):2225–2229. https://doi.org/10.1161/01.CIR.90.5.2225.Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation. 1994;90(5):2225–2229. https://doi.org/10.1161/01.CIR.90.5.2225.Vaccarino V, Bremner JD. Stress and cardiovascular disease: an update. Nat Rev Cardiol. 2024;21(9):603–616. https://doi.org/10.1038/s41569-024-01024-y.Vaccarino V, Bremner JD. Stress and cardiovascular disease: an update. Nat Rev Cardiol. 2024;21(9):603–616. https://doi.org/10.1038/s41569-024-01024-y.Zhao B, Yao Y, Gao T. The effect of psychological intervention on the quality of life and rehabilitation outcome of stroke patients with anxiety and depression: A systematic review. Medicine. 2024;103(45):e40439. https://doi.org/10.1097/MD.0000000000040439.Zhao B, Yao Y, Gao T. The effect of psychological intervention on the quality of life and rehabilitation outcome of stroke patients with anxiety and depression: A systematic review. Medicine. 2024;103(45):e40439. https://doi.org/10.1097/MD.0000000000040439.Thurston RC, Rewak M, Kubzansky LD. An anxious heart: anxiety and the onset of cardiovascular diseases. Prog Cardiovasc Dis. 2013;55(6):524–537. https://doi.org/10.1016/j.pcad.2013.03.007.Thurston RC, Rewak M, Kubzansky LD. An anxious heart: anxiety and the onset of cardiovascular diseases. Prog Cardiovasc Dis. 2013;55(6):524–537. https://doi.org/10.1016/j.pcad.2013.03.007.Shah RM, Doshi S, Shah S, Patel S, Li A, Diamond JA. Impacts of Anxiety and Depression on Clinical Hypertension in Low-Income US Adults. High Blood Press Cardiovasc Prev. 2023;30(4):337–342. https://doi.org/10.1007/s40292-023-00584-3.Shah RM, Doshi S, Shah S, Patel S, Li A, Diamond JA. Impacts of Anxiety and Depression on Clinical Hypertension in Low-Income US Adults. High Blood Press Cardiovasc Prev. 2023;30(4):337–342. https://doi.org/10.1007/s40292-023-00584-3.Jonas BS, Lando JF. Negative affect as a prospective risk factor for hypertension. Psychosom Med. 2000;62(2):188–196. https://doi.org/10.1097/00006842-200003000-00006.Jonas BS, Lando JF. Negative affect as a prospective risk factor for hypertension. Psychosom Med. 2000;62(2):188–196. https://doi.org/10.1097/00006842-200003000-00006.Zhou J, Fangma Y, Chen Z, Zheng Y. Post-Stroke Neuropsychiatric Complications: Types, Pathogenesis, and Therapeutic Intervention. Aging Dis. 2023;14(6):2127–2152. https://doi.org/10.14336/AD.2023.0310-2.Zhou J, Fangma Y, Chen Z, Zheng Y. Post-Stroke Neuropsychiatric Complications: Types, Pathogenesis, and Therapeutic Intervention. Aging Dis. 2023;14(6):2127–2152. https://doi.org/10.14336/AD.2023.0310-2.Lei XY, Chen LH, Qian LQ, Lu XD. Psychological interventions for post-stroke anxiety and depression: Current approaches and future perspectives. World J Psychiatry. 2025;15(6):103270. https://doi.org/10.5498/wjp.v15.i6.103270.Lei XY, Chen LH, Qian LQ, Lu XD. Psychological interventions for post-stroke anxiety and depression: Current approaches and future perspectives. World J Psychiatry. 2025;15(6):103270. https://doi.org/10.5498/wjp.v15.i6.103270.Isensee B, Wittchen HU, Stein MB, Höfler M, Lieb R. Smoking increases the risk of panic: findings from a prospective community study. Arch Gen Psychiatry. 2003;60(7):692–700. https://doi.org/10.1001/archpsyc.60.7.692.Isensee B, Wittchen HU, Stein MB, Höfler M, Lieb R. Smoking increases the risk of panic: findings from a prospective community study. Arch Gen Psychiatry. 2003;60(7):692–700. https://doi.org/10.1001/archpsyc.60.7.692.Hoertel N, Le Strat Y, De Maricourt P, Limosin F, Dubertret C. Are subjects in treatment trials of panic disorder representative of patients in routine clinical practice? Results from a national sample. J Affect Disord. 2013;146(3):383–389. https://doi.org/10.1016/j.jad.2012.09.023.Hoertel N, Le Strat Y, De Maricourt P, Limosin F, Dubertret C. Are subjects in treatment trials of panic disorder representative of patients in routine clinical practice? Results from a national sample. J Affect Disord. 2013;146(3):383–389. https://doi.org/10.1016/j.jad.2012.09.023.Muotri RW, Bernik MA. Panic disorder and exercise avoidance. Braz J Psychiatry. 2014;36(1):68–75. https://doi.org/10.1590/1516-4446-2012-1012.Muotri RW, Bernik MA. Panic disorder and exercise avoidance. Braz J Psychiatry. 2014;36(1):68–75. https://doi.org/10.1590/1516-4446-2012-1012.Эбзеева ЕЮ, Миронова ЕВ, Долдо НМ. Тревожные расстройства в практике врача первичного звена. Поликлиника. 2023;3(2):55–58. Режим доступа: https://www.poliklin.ru/imagearticle/2023-3-2%20Revma/Poliklinika_3(2)_Nevro_2023_page_55-59.pdf.Ebzeeva EYu, Mironova EV, Doldo NM. Anxiety disorders in the practice of a primary care physician. Poliklinika. 2023;3(2):55–58. (In Russ.) Available at: https://www.poliklin.ru/imagearticle/2023-3-2%20Revma/Poliklinika_3(2)_Nevro_2023_page_55-59.pdf.Эбзеева ЕЮ, Полякова ОА. Тревожные расстройства и нарушения сна. Медицинский совет. 2022;16(11):108–113. https://doi.org/10.21518/2079-701X-2022-16-11-108-113.Ebzeeva EYu, Polyakova OA. Anxiety and sleep disorders. Meditsinskiy Sovet. 2022;16(11):108–113. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-11-108-113.Ojagbemi A, Akinyemi J, Owolabi M, Akinyemi R, Arulogun O, Gebregziabher M et al. Predictors and prognoses of new onset post-stroke anxiety at one year in black Africans. J Stroke Cerebrovasc Dis. 2020;29:105082. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105082.Ojagbemi A, Akinyemi J, Owolabi M, Akinyemi R, Arulogun O, Gebregziabher M et al. Predictors and prognoses of new onset post-stroke anxiety at one year in black Africans. J Stroke Cerebrovasc Dis. 2020;29:105082. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105082.Wang J, Zhao D, Lin M, Huang X, Shang X. Post-stroke Anxiety Analysis via Machine Learning Methods. Front Aging Neurosci. 2021;13:657937. https://doi.org/10.3389/fnagi.2021.657937.Wang J, Zhao D, Lin M, Huang X, Shang X. Post-stroke Anxiety Analysis via Machine Learning Methods. Front Aging Neurosci. 2021;13:657937. https://doi.org/10.3389/fnagi.2021.657937.Almhdawi KA, Alazrai A, Kanaan S, Shyyab AA, Oteir AO, Mansour ZM, Jaber H. Post-stroke depression, anxiety, and stress symptoms and their associated factors: A cross-sectional study. Neuropsychol Rehabil. 2021;31:1091–1104. https://doi.org/10.1080/09602011.2020.1760893.Almhdawi KA, Alazrai A, Kanaan S, Shyyab AA, Oteir AO, Mansour ZM, Jaber H. Post-stroke depression, anxiety, and stress symptoms and their associated factors: A cross-sectional study. Neuropsychol Rehabil. 2021;31:1091–1104. https://doi.org/10.1080/09602011.2020.1760893.Gelenberg AJ. Psychiatric and Somatic Markers of Anxiety: Identification and Pharmacologic Treatment. Prim Care Companion J Clin Psychiatry. 2000;2(2):49–54. https://doi.org/10.4088/pcc.v02n0204.Gelenberg AJ. Psychiatric and Somatic Markers of Anxiety: Identification and Pharmacologic Treatment. Prim Care Companion J Clin Psychiatry. 2000;2(2):49–54. https://doi.org/10.4088/pcc.v02n0204.Эбзеева ЕЮ, Остроумова ОД, Миронова ЕВ, Долдо НМ. Психологический стресс и заболевания сердечно-сосудистой системы. Клинический случай. Медицинский совет. 2022;16(23):110–116. https://doi.org/10.21518/2079-701X-2022-16-23-110-116.Ebzeeva EYu, Ostroumova OD, Mironova EV, Doldo NM. Psychological stress and cardiovascular diseases: clinical case. Meditsinskiy Sovet. 2022;16(23):110–116. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-23-110-116.Васильева АВ. Использование мобильного приложения «Невросканер» в диагностике тревожных расстройств и выборе терапии. Лечащий врач. 2020. Режим доступа: https://www.lvrach.ru/author/11578820.Vasilyeva AV. Using the Neuroscanner mobile app in diagnosing anxiety disorders and choosing therapy. Lechaschi Vrach. 2020. (In Russ.) Available at: https://www.lvrach.ru/author/11578820.Васильева АВ. Актуальные проблемы диагностики депрессивных расстройств. Лечащий врач. 2020. Режим доступа: https://www.lvrach.ru/partners/velaxin/15437705.Vasilyeva AV. Actual problems of diagnosis of depressive disorders. Lechaschi Vrach. 2020. (In Russ.) Available at: https://www.lvrach.ru/partners/velaxin/15437705.Иванова ЛА. Терапия тревожных расстройств в общесоматической практике. Acta Biomedica Scientifica. 2017;2(5-2):121–124. https://doi.org/10.12737/article_5a3a0e7b6a3885.64967546.Ivanova LA. Anxiety disorders therapy in general practice. Acta Biomedica Scientifica. 2017;2(5-2):121–124. (In Russ.) https://doi.org/10.12737/article_5a3a0e7b6a3885.64967546.Nungulo VN, Gonçalves M, Henriques MA, Baixinho CL. Effectiveness of psychoeducational intervention in promoting post-stroke self-care: a systematic literature review. Front Rehabil Sci. 2025;6:1569526. https://doi.org/10.3389/fresc.2025.1569526.Nungulo VN, Gonçalves M, Henriques MA, Baixinho CL. Effectiveness of psychoeducational intervention in promoting post-stroke self-care: a systematic literature review. Front Rehabil Sci. 2025;6:1569526. https://doi.org/10.3389/fresc.2025.1569526.Le HT, Honma K, Annaka H, Sun S, Nomura T. Effectiveness of Problem-Solving Therapy in Improving Patient Mental Health, Function, Quality of Life, and Mortality Post-Stroke: A Systematic Review. Behav Sci. 2024;14(6):446. https://doi.org/10.3390/bs14060446.Le HT, Honma K, Annaka H, Sun S, Nomura T. Effectiveness of Problem-Solving Therapy in Improving Patient Mental Health, Function, Quality of Life, and Mortality Post-Stroke: A Systematic Review. Behav Sci. 2024;14(6):446. https://doi.org/10.3390/bs14060446.Domínguez-Borràs J, Vuilleumier P. Amygdala function in emotion, cognition, and behavior. Handb Clin Neurol. 2022;187:359–380. https://doi.org/10.1016/B978-0-12-823493-8.00015-8.Domínguez-Borràs J, Vuilleumier P. Amygdala function in emotion, cognition, and behavior. Handb Clin Neurol. 2022;187:359–380. https://doi.org/10.1016/B978-0-12-823493-8.00015-8.Wu CK, Huang YT, Lee JK, Jimmy Juang JM, Tsai CT, Lai LP et al. Anti-anxiety drugs use and cardiovascular outcomes in patients with myocardial infarction: a national wide assessment. Atherosclerosis. 2014;235(2):496–502. https://doi.org/10.1016/j.atherosclerosis.2014.05.918.Wu CK, Huang YT, Lee JK, Jimmy Juang JM, Tsai CT, Lai LP et al. Anti-anxiety drugs use and cardiovascular outcomes in patients with myocardial infarction: a national wide assessment. Atherosclerosis. 2014;235(2):496–502. https://doi.org/10.1016/j.atherosclerosis.2014.05.918.Horváth EJ, Horváth K, Hámori T, Fekete MI, Sólyom S, Palkovits M. Anxiolytic 2,3-benzodiazepines, their specific binding to the basal ganglia. Prog Neurobiol. 2000;60(4):309–342. https://doi.org/10.1016/s0301-0082(99)00020-9.Horváth EJ, Horváth K, Hámori T, Fekete MI, Sólyom S, Palkovits M. Anxiolytic 2,3-benzodiazepines, their specific binding to the basal ganglia. Prog Neurobiol. 2000;60(4):309–342. https://doi.org/10.1016/s0301-0082(99)00020-9.Левин ОС. Тревожные расстройства в общеклинической практике. Медицинский совет. 2017;(10):36–40. https://doi.org/10.21518/2079-701X-2017-10-36-40.Levin OS. Anxiety disorders in clinical practice. Meditsinskiy Sovet. 2017;(10):36–40. (In Russ.) https://doi.org/10.21518/2079-701X-2017-10-36-40.Wu CK, Huang YT, Lee JK, Jimmy Juang JM, Tsai CT, Lai LP et al. Anti-anxiety drugs use and cardiovascular outcomes in patients with myocardial infarction: a national wide assessment. Atherosclerosis. 2014;235(2):496–502. https://doi.org/10.1016/j.atherosclerosis.2014.05.918.Wu CK, Huang YT, Lee JK, Jimmy Juang JM, Tsai CT, Lai LP et al. Anti-anxiety drugs use and cardiovascular outcomes in patients with myocardial infarction: a national wide assessment. Atherosclerosis. 2014;235(2):496–502. https://doi.org/10.1016/j.atherosclerosis.2014.05.918.Abdelmonaem AA, Abdel-Aziz AM, Ibrahim YF, Abdelzaher WY, Amgad Mohammed N, Marey H et al. Cardioprotective effect of tofisopam against isoprenaline-induced myocardial infarction in rats via modulation of NLRP3IL-1βcaspase-1 pathway. Immunopharmacol Immunotoxicol. 2024;46(6):902–911. https://doi.org/10.1080/08923973.2024.2421528.Abdelmonaem AA, Abdel-Aziz AM, Ibrahim YF, Abdelzaher WY, Amgad Mohammed N, Marey H et al. Cardioprotective effect of tofisopam against isoprenaline-induced myocardial infarction in rats via modulation of NLRP3IL-1βcaspase-1 pathway. Immunopharmacol Immunotoxicol. 2024;46(6):902–911. https://doi.org/10.1080/08923973.2024.2421528.Hovi-Viander M, Kanto J, Scheinin H, Scheinin M. Tofisopam and midazolam: differences in clinical effects and in changes of CSF monoamine metabolites. Br J Clin Pharmacol. 1985;20(5):492–496. https://doi.org/10.1111/j.1365-2125.1985.tb05105.x.Hovi-Viander M, Kanto J, Scheinin H, Scheinin M. Tofisopam and midazolam: differences in clinical effects and in changes of CSF monoamine metabolites. Br J Clin Pharmacol. 1985;20(5):492–496. https://doi.org/10.1111/j.1365-2125.1985.tb05105.x.Löw K, Crestani F, Keist R, Benke D, Brünig I, Benson JA et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science. 2000;290(5489):131–134. https://doi.org/10.1126/science.290.5489.131.Löw K, Crestani F, Keist R, Benke D, Brünig I, Benson JA et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science. 2000;290(5489):131–134. https://doi.org/10.1126/science.290.5489.131.Horváth EJ, Horváth K, Hámori T, Fekete MI, Sólyom S, Palkovits M. Anxiolytic 2,3-benzodiazepines, their specific binding to the basal ganglia. Prog Neurobiol. 2000;60(4):309–342. https://doi.org/10.1016/s0301-0082(99)00020-9.Horváth EJ, Horváth K, Hámori T, Fekete MI, Sólyom S, Palkovits M. Anxiolytic 2,3-benzodiazepines, their specific binding to the basal ganglia. Prog Neurobiol. 2000;60(4):309–342. https://doi.org/10.1016/s0301-0082(99)00020-9.Kalashnikov SV, Kalashnikova EA, Kokarovtseva SN. Immunomodulating effects of tofizopam (Grandaxin) and diazepam in vitro. Mediators Inflamm. 2002;11(1):53–59. https://doi.org/10.1080/09629350210309.Kalashnikov SV, Kalashnikova EA, Kokarovtseva SN. Immunomodulating effects of tofizopam (Grandaxin) and diazepam in vitro. Mediators Inflamm. 2002;11(1):53–59. https://doi.org/10.1080/09629350210309.Ковалев ДВ, Скибицкий ВВ, Курзанов АН, Пономарева АИ. Эффективность комбинированной с анксиолитиком антигипертензивной фармакотерапии у больных с артериальной гипертонией и тревожными расстройствами. Российский кардиологический журнал. 2017;(4):99–104. https://doi.org/10.15829/1560-4071-2017-4-99-104.Kovalev DV, Skibitsky VV, Kurzanov AN, Ponomareva AI. The efficacy of antihypertensive treatment combination with anxiolytics in hypertensives with anxiety disorder. Russian Journal of Cardiology. 2017;(4):99–104. (In Russ.) https://doi.org/10.15829/1560-4071-2017-4-99-104.Старостина ЕГ, Мошняга ЕН, Бобров АЕ. Эффективность и безопасность медикаментозной терапии тревожных расстройств у больных сахарным диабетом. Сахарный диабет. 2010;13(3):52–55. https://doi.org/10.14341/2072-0351-5488.Starostina EG, Moshnyaga EN, Bobrov AE. Efficacy and safety of drug therapy for anxiety disorders in patients with diabetes mellitus. Diabetes Mellitus. 2010;13(3):52–55. (In Russ.) https://doi.org/10.14341/2072-0351-5488.Сычев ДА, Остроумова ОД (ред.). Лекарственно-индуцированные заболевания. Том II. М.: Прометей; 2022. 536 c.Сычев ДА, Остроумова ОД (ред.). Лекарственно-индуцированные заболевания. Том II. М.: Прометей; 2022. 536 c.Артемов АН, Василенко ИВ, Триф ЮВ, Маркина ВА. Оценка эффективности грандаксина при постинсультном генерализованном тревожном расстройстве. Научно-центральный вестник Центрального Черноземья. 2011;(44):10–14. Режим доступа: https://elibrary.ru/sagsqv.Artemov AN, Vasilenko IV, Trif YuV, Markina VA. Estimation of the effectiveness of grandaxin with the anxious disorder after stroke. Medical Scientific Bulletin of Central Chernozemye. 2011;(44):10–14. (In Russ.) Available at: https://elibrary.ru/sagsqv.

The authors declare that there are no conflicts of interest present.